Per Reuters, Volkswagen AG announced that it will recall roughly 220,000 units of new Polo vehicles due to defective rear seatbelt lock. Additionally, 191,000 cars of the company’s Spanish subsidiary Seat are also affected. The recall will begin in the coming weeks. The affected vehicles have a technical problem, which in unusual situations could release the rear left seatbelt.
The worldwide recall is restricted to regions where Seat and Polo cars are sold. The affected models under Seat include the 2018 models of Arona, and 2017 and 2018 models of Ibiza.
Almost at the same time, Volkswagen’s subsidiary Audi AG announced that will present a software upgrade to Germany's motor authority KBA for roughly 60,000 cars after detecting emission-related problems. Further, the auto manufacturer stopped selling its A6 and A7 models after finding a problem with emissions software for a specific type of diesel engine.
Volkswagen AG Price and Consensus
In March, the company announced roughly 4.86 million vehicle recall in China due to Takata-airbag problem. The recall was applicable to both imported and locally-manufactured vehicles.
These recalls are likely to add to the company’s expenses, which are already hit by penalties for the emission scandal of September 2015. Further, this is likely to reduce the already-dented consumer confidence in the brand.
Price Performance
In a month’s time, Volkswagen’s stock has declined 4.6%, underperforming 2.2% gain of the industry it belongs to.
Zacks Rank & Other Stocks to Consider
Volkswagen currently carries a Zacks Rank #2 (Buy). Other top-ranked stocks in the auto space are Fiat Chrysler Automobiles N.V. , Oshkosh Corporation (OSK - Free Report) and General Motors Corporation (GM - Free Report) . Fiat Chrysler and Oshkosh sport a Zacks Rank #1 (Strong Buy) while General Motors carries a Zacks Rank of 2. You can see the complete list of today’s Zacks #1 Rank stocks here.
Fiat Chrysler has expected long-term growth rate of 23.7%. In a year’s time, shares of the company have gained 103.7%.
Oshkosh has expected long-term growth rate of 18.3%. Shares of the company have risen 11.9% over the past year.
General Motors has expected long-term growth rate of 5.5%. Over the past year, shares of the company have gained 9%.
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Click here to see the 5 stocks >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Per Reuters, Volkswagen AG announced that it will recall roughly 220,000 units of new Polo vehicles due to defective rear seatbelt lock. Additionally, 191,000 cars of the company’s Spanish subsidiary Seat are also affected. The recall will begin in the coming weeks. The affected vehicles have a technical problem, which in unusual situations could release the rear left seatbelt.
The worldwide recall is restricted to regions where Seat and Polo cars are sold. The affected models under Seat include the 2018 models of Arona, and 2017 and 2018 models of Ibiza.
Almost at the same time, Volkswagen’s subsidiary Audi AG announced that will present a software upgrade to Germany's motor authority KBA for roughly 60,000 cars after detecting emission-related problems. Further, the auto manufacturer stopped selling its A6 and A7 models after finding a problem with emissions software for a specific type of diesel engine.
Volkswagen AG Price and Consensus
In March, the company announced roughly 4.86 million vehicle recall in China due to Takata-airbag problem. The recall was applicable to both imported and locally-manufactured vehicles.
These recalls are likely to add to the company’s expenses, which are already hit by penalties for the emission scandal of September 2015. Further, this is likely to reduce the already-dented consumer confidence in the brand.
Price Performance
In a month’s time, Volkswagen’s stock has declined 4.6%, underperforming 2.2% gain of the industry it belongs to.
Zacks Rank & Other Stocks to Consider
Volkswagen currently carries a Zacks Rank #2 (Buy). Other top-ranked stocks in the auto space are Fiat Chrysler Automobiles N.V. , Oshkosh Corporation (OSK - Free Report) and General Motors Corporation (GM - Free Report) . Fiat Chrysler and Oshkosh sport a Zacks Rank #1 (Strong Buy) while General Motors carries a Zacks Rank of 2. You can see the complete list of today’s Zacks #1 Rank stocks here.
Fiat Chrysler has expected long-term growth rate of 23.7%. In a year’s time, shares of the company have gained 103.7%.
Oshkosh has expected long-term growth rate of 18.3%. Shares of the company have risen 11.9% over the past year.
General Motors has expected long-term growth rate of 5.5%. Over the past year, shares of the company have gained 9%.
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Click here to see the 5 stocks >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on GM - FREE
Get the latest research report on OSK - FREE